NSAIDs and spinal manipulation did nothing to speed recovery. Most episodes of acute lower back pain will resolve spontaneously, and guideline-recommended treatment consists primarily of ...
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
Astronauts commonly reported acute and chronic pain during and after spaceflight, particularly in the lumbar spine. During and after spaceflight, astronauts experience lower back pain (LBP), lumbar ...
FDA approves Journavx, a non-opioid medication for moderate to severe acute pain. Learn about its efficacy and side effects.
GlobalData on MSN10d
FDA approves Vertex’s acute pain treatment JournavxThe FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.
Opens in a new tab or window NSAIDs, ketamine, and mid- to high-potency opioids reduced acute pediatric pain, but effects were ... or were supported by low- or very low-certainty evidence, Olejnik ...
A study by researchers at The George Institute for International Health in Australia found that it is rare for patients presenting to PCPs with acute lower back pain to have previously undiagnosed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback